EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Current insights and future directions of Li-Fraumeni syndrome

Mohammad-Salar Hosseini

Discover Oncology · 15.10.2024 · 15 (1)

DOI: 10.1007/s12672-024-01435-w ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Discover Oncology, online erschienen am 15.10.2024. Verfasst von Mohammad-Salar Hosseini. Beteiligte Einrichtung: Research Center for Integrative Medicine in Aging, Aging Research Institute, Tabriz University of Medical Sciences, Golgasht Street, Tabriz, 51666, E…. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 199 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Li-Fraumeni syndrome is a rare yet serious hereditary cancer predisposition syndrome, marked by a significant early-life increased risk of developing cancer. Primarily caused by germline mutations in the TP53 tumor suppressor gene, Li-Fraumeni syndrome is associated with a wide range of malignancies. Clinical management of Li-Fraumeni syndrome could be challenging, especially the lifelong surveillance and follow-up of patients which requires a multidisciplinary approach. Emerging insights into the molecular and clinical basis of Li-Fraumeni syndrome, coupled with advances in genomic technologies and targeted therapies, offer promise in optimizing risk assessment, early detection, and treatment strategies tailored to the unique clinical and molecular profiles of affected individuals. This review discusses Li-Fraumeni syndrome in more depth, reviewing molecular, genomic, epidemiological, clinical, and therapeutic aspects of this disease.

Schlagwörter

Stichwörter der Autor:innen

AYAAdolescents and young adults cancerCancer predisposition syndromesHereditary cancerLi-FraumeniTP53p53

Autor:innen und Institutionen

  • Research Center for Integrative Medicine in Aging, Aging Research Institute, Tabriz University of Medical Sciences, Golgasht Street, Tabriz, 51666, EA, Iran. hosseini.msalar@gmail.com.
  • Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. hosseini.msalar@gmail.com.
  • Research Center for Evidence-Based Medicine, Iranian EBM Center: A JBI Center of Excellence, Tabriz University of Medical Sciences, Tabriz, Iran. hosseini.msalar@gmail.com.

Zitieren

APA

Hosseini, M. S. (2024). Current insights and future directions of Li-Fraumeni syndrome. Discover Oncology, 15(1). https://doi.org/10.1007/s12672-024-01435-w

Vancouver

Hosseini MS. Current insights and future directions of Li-Fraumeni syndrome. Discover Oncology. 2024;15(1). doi:10.1007/s12672-024-01435-w

BibTeX
@article{Hosseini2024,
  author = {Hosseini, Mohammad-Salar},
  title = {Current insights and future directions of Li-Fraumeni syndrome},
  journal = {Discover Oncology},
  year = {2024},
  volume = {15},
  number = {1},
  doi = {10.1007/s12672-024-01435-w}
}
Kostenlos starten →